Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UPDATE: FDA Approves Kite Pharma's Yescarta BLA Supplement Allowing Short-Term -80°C Storage For Up To 90 Days At Authorized Treatment Centers; Supplement Approval Was On October 21, 2025

Author: Benzinga Newsdesk | October 28, 2025 11:46am

https://www.fda.gov/media/189364/download?attachment

Posted In: GILD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist